Exchange: NASDAQ·Updated 01:00 PM EDT
News
all
press releases
NVAX Stock Climbs As Partnership Model Keeps COVID Vaccine Cash Flow Open
Novavax said Sanofi and Takeda received clearances for an updated Nuvaxovid formulation for the 2026-2027 COVID season.
Stocktwits
More News
FDA Approves 3 New COVID-19 Vaccines
FDA Approves 3 New COVID-19 Vaccines Authored by Zachary Stieber via The Epoch Times, The Food and Drug Administration on Aug. 27 approved COVID-19 vaccines from Pfizer, Moderna, and Sanofi. A nurse prepares to give a COVID-19 vaccine to a child in Denver, Colo., on Nov. 3, 2021...
Zero Hedge
Top Stock Reports for NVIDIA, ExxonMobil & HSBC
NVIDIA, ExxonMobil and HSBC see growth from AI demand, energy expansion and Asia wealth momentum, but face distinct execution and market risks.
Zacks
SNY Stock Trading Above 50- & 200-Day SMAs: Buy, Hold or Sell?
Sanofi's stock trades above key moving averages as Dupixent and new drugs drive growth, while pipeline setbacks and vaccine weakness weigh.
Zacks
Sanofi Boasts a Dividend Yield of 5.4%, Trades Below 9x Earnings, and Just Got an FDA Win. Are Income Investors Missing a Rare Opportunity?
Key PointsThe FDA just approved the company's on-body injector for its blood cancer drug...
Nasdaq News: Markets
Regeneron Secures FDA Approval for Rare Genetic Disorder Drug
REGN's Pasatru wins FDA approval for FOP, cutting new HO lesions by 90% or more and reducing clinician-assessed flare-ups.
Zacks
Teva Rises 17% YTD: Should You Buy, Sell or Hold the Stock?
Teva's stock gains reflect stronger branded drug growth, a strengthening pipeline and improving finances, but generics and debt remain key risks.
Zacks
NVAX Q2 Earnings & Sales Beat Estimates, '26 Sales Outlook Raised
Novavax beat Q2 earnings and revenue estimates, raises its 2026 adjusted revenue outlook, cuts expense guidance and outlines potential Sanofi milestones ahead.
Zacks
BMRN Stock Up as Q2 Earnings Beat on Sales Growth, 2026 Outlook Raised
BioMarin stock rises on Q2 sales beat and raises 2026 outlook, highlighting strong Voxzogo growth, Amicus additions and momentum in key therapies.
Zacks
PFE, MRK, SNY, MRNA In Focus As Trump Reportedly Eyes Executive Order On Vaccines And Autism
The order’s contents remain unclear, and timing could shift, Bloomberg reported, citing people familiar with the matter.
Stocktwits

Advertisement|Remove ads.